Kinetek, Tyrogene Biotechnologies Inc. deal

Kinetek acquired Tyrogene Biotechnologies, a cancer company developing inhibitors of protein tyrosine phosphatase signaling proteins. Kinetek is developing drugs for signal transduction-related disea...